Addressing transportation barriers in oncology: existing programs and new solutions.

Humans Neoplasms / therapy Health Services Accessibility Transportation of Patients / methods Medical Oncology / organization & administration Patient Satisfaction Transportation / methods Clinical Trials as Topic
Cancer Clinical trials Health disparities Transportation

Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
29 Apr 2024
Historique:
received: 16 10 2023
accepted: 19 04 2024
medline: 30 4 2024
pubmed: 30 4 2024
entrez: 29 4 2024
Statut: epublish

Résumé

Transportation is an underrecognized, but modifiable barrier to accessing cancer care, especially for clinical trials. Clinicians, insurers, and health systems can screen patients for transportation needs and link them to transportation. Direct transportation services (i.e., ride-sharing, insurance-provided transportation) have high rates of patient satisfaction and visit completion. Patient financial reimbursements provide necessary funds to counteract the effects of transportation barriers, which can lead to higher trial enrollment, especially for low socioeconomic status and racially and ethnically diverse patients. Expanding transportation interventions to more cancer patients, and addressing knowledge, service, and system gaps, can help more patients access needed cancer care.

Identifiants

DOI: 10.1007/s00520-024-08514-2 PMID: 38684580
pubmed: 38684580
doi: 10.1007/s00520-024-08514-2
pii: 10.1007/s00520-024-08514-2
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

317

Informations de copyright

© 2024. The Author(s).

Références

JAMA Netw Open. 2021 Nov 1;4(11):e2133205
pubmed: 34748007
Am J Clin Oncol. 2020 Jan;43(1):43-46
pubmed: 31633516
J Health Care Poor Underserved. 2020;31(3):1457-1470
pubmed: 33416705
J Womens Health (Larchmt). 2012 Jul;21(7):713-6
pubmed: 22747427
JCO Oncol Pract. 2022 Sep;18(9):652-662
pubmed: 35834768
JCO Oncol Pract. 2022 Jun;18(6):e915-e924
pubmed: 35196064
Contemp Clin Trials. 2022 Oct;121:106922
pubmed: 36096281
Gynecol Oncol. 2023 Aug;175:25-31
pubmed: 37300995
JAMA. 2004 Jun 9;291(22):2720-6
pubmed: 15187053
Oncologist. 2016 Apr;21(4):467-74
pubmed: 26975867
J Thorac Oncol. 2011 Jan;6(1):98-102
pubmed: 21150469
JAMA Oncol. 2024 Apr 1;10(4):425-426
pubmed: 38300547
J Immigr Minor Health. 2020 Feb;22(1):74-81
pubmed: 31758420
Adv Cancer Res. 2020;146:139-166
pubmed: 32241387

Auteurs

Sophia Pringle (S)

Leonard Davis Institute of Health Economics, Saint Joseph's University, Philadelphia, PA, USA.

Emily M Ko (EM)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Pennsylvania Health Systems, Philadelphia, PA, USA.
Leonard Davis Institute of Health Economics, University of Pennsylvania Health Systems, Philadelphia, PA, USA.
Penn Center for Cancer Care Innovation, Abramson Cancer Center, University of Pennsylvania Health Systems, Philadelphia, PA, USA.

Meredith Doherty (M)

Leonard Davis Institute of Health Economics, University of Pennsylvania Health Systems, Philadelphia, PA, USA.
Penn Center for Cancer Care Innovation, Abramson Cancer Center, University of Pennsylvania Health Systems, Philadelphia, PA, USA.
School of Social Policy and Practice, University of Pennsylvania, Philadelphia, PA, USA.

Anna Jo Bodurtha Smith (AJB)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Pennsylvania Health Systems, Philadelphia, PA, USA. annajo.smith@pennmedicine.upenn.edu.
Leonard Davis Institute of Health Economics, University of Pennsylvania Health Systems, Philadelphia, PA, USA. annajo.smith@pennmedicine.upenn.edu.
Penn Center for Cancer Care Innovation, Abramson Cancer Center, University of Pennsylvania Health Systems, Philadelphia, PA, USA. annajo.smith@pennmedicine.upenn.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Addressing transportation barriers in...
questionsmedicales.fr › Tumeurs › Addressing transportation barriers in...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Prestations des soins de santé › Accessibilité des services de santé › Addressing transportation barriers in...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Prestations des soins de santé › Accessibilité des services de santé › Transport sanitaire › Addressing transportation barriers in...
questionsmedicales.fr › Professions de santé › Médecine › Médecine interne › Oncologie médicale › Addressing transportation barriers in...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Satisfaction des patients › Addressing transportation barriers in...
questionsmedicales.fr › Technologie, industrie et agriculture › Transports › Addressing transportation barriers in...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études cliniques comme sujet › Essais cliniques comme sujet › Addressing transportation barriers in...